US Patent Issued to USA Elixiria Biotech on Feb. 10 for "Compound as PPAR agonist and application thereof" (American, Chinese Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,653, issued on Feb. 10, was assigned to USA Elixiria Biotech Inc. (Hartsdale, N.Y.).

"Compound as PPAR agonist and application thereof" was invented by Lihai Zhang (Hartsdale, N.Y.) and Min Hu (Heilongjiang Province OT, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds as PPAR agonists and their application, involving a new class of peroxisome proliferator-activated receptor (PPAR) gamma receptor agonist, which can inhibit the production of mitochondrial reactive oxygen species, and most of which can readily cross the blood-brain barrier. The present invention also includes pharmaceutical uses of the compo...